课题基金 / 基金详情

SKELETAL MYOFIBER TENSION IN HYPERTROPHIC CARDIOLOGY

SKELETAL MYOFIBER TENSION IN HYPERTROPHIC CARDIOLOGY
肥厚型心脏病中的骨骼肌纤维张力
批准号:
3843407
负责人:
L FANANAPAZIR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

L FANANAPAZIR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hypertrophic cardiomyopathy is the most common inherited heart disease and is the most important cause of sudden death in the young. Recently, a gene which controls the production of the main protein of the heart, beta myosin heavy chain gene, located on chromosome 14, has been linked to the disease in some kindreds with hypertrophic cardiomyopathy, We have found distinct mutations in the beta myosin heavy chain gene in several kindreds with hypertrophic cardiomyopathy. We have also shown that although the disease affects the heart predominantly, the cardiac protein is also expressed in skeletal tissue and that the mutant RNA and protein are also to be found in skeletal muscle. This has led us to determine whether the single myofibers in skeletal muscle has abnormal mechanical function. Isometric tension generated by single skinned soleus muscle fibers was measured in affected individuals with identified mutations. This was significantly reduced in several patients with a mutation (403ArgGln) associated with a malignant prognosis but not in other mutations. This suggests that hypertrophic cardiomyopathy patients with distinct mutations in the cardiac beta myosin heavy chain gene may have skeletal muscle with abnormal mechanical properties and that the pathophysiology of the disease is varied at a cellular and molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREDICTION OF ADVERSE EFFECTS OF AMIODARONE BY SIGNAL AVERAGING IN HCM PATIENTS
INDUCTION OF MALIGNANT VENTRICULAR TACHYCARDIA ON AMIODARONE IN HCM PATIENTS
CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
INHERITED CARDIAC DISEASES--HYPERTROPHIC CARDIOMYOPATHY
海外基金